GenScript is best known for its gene synthesis capabilities, which we estimate is more than half of the life science services and products segment. In 2014, GenScript was the leader in gene synthesis, ...

Panel discussions brought to life important insights into how AI could change the face of biopharma drug discovery in 2026 and beyond PISCATAWAY, N.J., Jan. 29, 2026 /PRNewswire/ -- GenScript Biotech ...

PISCATAWAY, N.J., July 9, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that it has been ...

NANJING, China, Jan. 4, 2024 /PRNewswire/ -- GenScript Biotech, a global leader in life science research and manufacturing services, along with its subsidiaries GenScript ProBio and Legend Biotech ...

R&D Innovation to Lead the Future, Deepening Customer Value Creation From the performance during the 2023 reporting period, GenScript Group's overall development is optimistic, with each business ...

In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...

PISCATAWAY, N.J., April 23, 2024 /PRNewswire/ -- GenScript Biotech Corporation (GenScript), one of the world's leading providers of life-science research tools and services, and Multiply Labs, a ...

NANJING, China and SEOUL, South Korea, Nov. 18, 2019 /PRNewswire/ -- GenScript Biologics, a world leading bio-pharmaceutical CDMO company, announced today that it entered into an agreement with ABL ...

Genscript Biotech ( (HK:1548)) just unveiled an announcement. Genscript Biotech Corporation has announced amendments to its 2019 and 2021 Restricted Share Unit (RSU) Schemes. The changes include the ...

PISCATAWAY, N.J., March 12, 2024 /PRNewswire/ -- On March 11, 2024, GenScript Biotech Corporation (HK.1548), a world's leading technology and service provider of life science R&D and manufacturing, ...